UKAD 2022 UKAD vs Matthew Richardson

In February 2022 the United Kingdom Anti-Doping (UKAD) has reported anti-doping rule violations against the weightlifter Matthew Richardson for possession and attempted use of multiple prohibited substances: Clomifene, Human chorionic gonadotrophin (hCG), Mesterolone and Tamoxifen.

In August 2020 the Athlete already gave to UKAD a prompt admissions, waived his right for a hearing, accepted a provisional suspension and the sanction proposed by UKAD.

The Athlete fully admitted that in 2019 he had purchased multiple substances and that he knew that these substances were prohibited. He stated that eventially he had decided not to use these substances.

Therefore UKAD decides on 18 August 2022 to impose a 4 year period of ineligibility on the Athlete, starting backdated on 18 August 2020.

Original document

Parameters

Legal Source
National Decisions
Date
18 August 2022
Original Source
UK Anti-Doping (UKAD)
Country
United Kingdom
Language
English
ADRV
Possession
Use / attempted use
Legal Terms
Acceptance of sanction
Commencement of ineligibility period
Prompt / Timely Admission
Waiver of "right to be heard"
Sport/IFs
Weightlifting (IWF) - International Weightlifting Federation
Other organisations
UK Anti-Doping (UKAD)
Laboratories
London, United Kingdom: Drug Control Centre
Doping classes
S1. Anabolic Agents
S2. Peptide Hormones, Growth Factors
S4. Hormone And Metabolic Modulators
Substances
Clomifene
Human chorionic gonadotrophin (hCG)
Mesterolone
Tamoxifen
Document type
Pdf file
Date generated
3 October 2022
Date of last modification
7 November 2022
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin